Canna Pacific is a cannabinoid biotech company with a team of experienced pharmaceutical experts, doctors and researchers working to bring unique delivery systems and symptom specific formulations to the market.

They offer services such as plant science research and development, growing and extraction, as well as clinical data acquisition. They have a strong doctor and clinical engagement model that drives sales of current products. They also cater to healthcare professionals with their free online SAS B prescribing tool that streamlines approval and prescriptions – this comes together with advice for prescribing and dose titration, and free education, training, videos and case studies.

Canna Pacific’s cultivation facility is in northern NSW, with a production area that includes a 10,000 sqm Dutch glasshouse and 3 hectares of high-security outdoor cultivation. The facility can produce over 15,000 kg of premium cannabis flower per year, and the greenhouse and production areas are being constructed to comply with GACP and GMP standards. The facility will create an optimal environment for cannabis cultivation and production, utilising high-tech automated climate control, light deprivation and fertigation systems.

Once a patient has approval from both the TGA and the State Health Department, Canna Pacific’s products can be ordered through Anspec by calling (02) 8438 8681 or by emailing [email protected], or they can present their script for medicinal cannabis at the pharmacy of their choice.

Canna Pacific can be found at their head office located at 5/109 Ocean Street, Dudley 2290 NSW, Australia. For more information about collaboration or their products, they can be contacted by phone at +61 (2) 4942 6021 or by email at [email protected].